VLN:NYSEValens Semiconductor Ltd. Analysis
Data as of 2026-09-15 - not real-time
$1.62
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $1.62, Valens Semiconductor Ltd. shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has gained 3.2% over the past 30 days. Relative strength is 38.7 — approaching oversold — and the MACD signal is bearish. Watch $1.60 as support and $2.00 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 146.9% above where the shares trade now. Revenue is growing at 6.1% on a -45.2% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 55.6%, a beta of 4.14 and a maximum drawdown of 58.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 2 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 146.9% above where the shares trade now. Revenue is growing at 6.1% on a -45.2% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 55.6%, a beta of 4.14 and a maximum drawdown of 58.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 2 out of 10.
Top Market Events
PTK Acquisition VLN delivered earnings and revenue surprises of 0.Yahoo Finance1monValens Semiconductor Ltd.Detailed price information for Valens Semiconductor Ltd VLN-N from The Globe and Mail including charting and trades.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 1.83
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 1.83
- Analyst targets imply +146.9% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -45.2%
- Analyst targets imply +146.9% versus the current price
- Negative return on equity of -30.4%
Key Metrics & Analysis
Financial Health
Revenue Growth6.10%
Profit Margin-45.23%
P/E Ratio-21.1
ROE-30.38%
ROA-15.72%
Debt/Equity8.26
P/B Ratio1.7
Op. Cash Flow$-13935000
Free Cash Flow$-6985250
Industry P/E32.6
Technical Analysis
TrendBearish
RSI38.7
Support$1.60
Resistance$2.00
MA 20$1.75
MA 50$1.77
MA 200$1.83
MACDBearish
VolumeStable
Fear & Greed Index90.84
Valuation
Target Price$4.00
Upside/Downside146.91%
GradeFair
TypeBlend
Risk Assessment
Beta4.14
Volatility55.62%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.